InvestorsHub Logo
Followers 73
Posts 6212
Boards Moderated 0
Alias Born 05/01/2011

Re: rosemountbomber post# 412730

Friday, 07/21/2023 10:17:27 AM

Friday, July 21, 2023 10:17:27 AM

Post# of 425915
For Big Pharma selling this in Europe would be 10x easier. No apparatus to build, and deep existing relationships with regulators and other interested parties.

And they would manage the runoff in the US way better as well.

The drug is worth at least $5 per share to a Big Pharma. But they will be stingy. Because they can be. They can smell the stink of vulnerability on this thing.

"The biggest obstacles to our progress exist within our own lives in the form of cowardice and the tendency to give up. Breaking through these barriers will unleash a surging wave of change." -- Daisaku Ikeda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News